Plenary Session 1: IBD / Small Intestine / Unclassified
Wednesday, October 22
8:30 am – 10:15 am
Moderators: Francis A. Farraye, MD, MSc, FACG
Jonathan A. Leighton MD, FACG

Oral 63: The Risk of a Second Non-Melanoma Skin Cancer With Thiopurine and Anti-TNF Use in Inflammatory Bowel Disease

Frank I. Scott, MD, MSCE, Ronac Mamtani, MD, MSCE, Colleen Brensinger, MS, Kevin Haynes, PharmD, MSCE, Zelma C. Chiesa-Fuxench, MD, Jie Zhang, PhD, Lang Chen, MD, PhD, Fenglong Xie, MS, David J. Margolis, MD, PhD, Jeffrey R. Curtis, MD, MS, MPH, James D. Lewis, MD, MSCE, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Read abstract


 

Embargo Policy

All research presented at the ACG Annual Scientific Meeting is strictly embargoed until 8:00 a.m. on the first day of the Annual Meeting. For 2014, this is Monday, October 20 at 8:00 a.m. EDT.